LABT
Lakewood-Amedex Biotherapeutics Inc.
Going-concern doubt
— flagged May 22, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, substantial doubt regarding the Company’s ability to continue as a going concern within one year after the date that these financial statements are issued has not been alleviated.”View the 10-Q filed May 22, 2026
Company with tickers: LABT
Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Short Squeeze Score
37/100
Short interest 0.3% of shares — P27
Days to cover 1.0 — P14
Short-volume trend +4.2% — P68
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-05-29). Equal-weight mean of the available factors.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
| 2026-05-29 | 39,018 | 148,551 | -109,533 | 1.00 |
| 2026-05-15 | 148,551 | 75,707 | +72,844 | 1.00 |
| 2026-04-30 | 75,707 | 0 | +75,707 | 1.00 |
Showing 1–3 of 3 settlements